LY2228820 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

LY2228820 is a novel and potent p38MAPK inhibitor with potent antiinflammatory activity. LY2228820 significantly inhibited phosphorylation of MAPKAPK2 and/or HSP27, down stream targets of p38MAPK, in both multiple myeloma (MM) cell lines and LT-BMSCs. LY2228820 is a potential candidate to improve MM patient outcome both by enhancing the effect of Bortezomib (B675700) and by reducing osteoskeletal events.

LY2228820 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

LY2228820 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Capot Chemical Co.,Ltd.	+86-（0）57185586718 +86-13336195806	sales@capot.com	China	29640	60
ATK CHEMICAL COMPANY LIMITED	+undefined-21-51877795	ivan@atkchemical.com	China	33024	60
career henan chemical co	+86-0371-86658258 +8613203830695	factory@coreychem.com	China	29792	58
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32467	58
Dideu Industries Group Limited	+86-29-89586680 +86-15129568250	1026@dideu.com	China	28760	58
BOC Sciences	16314854226; +16314854226	inquiry@bocsci.com	United States	19853	58
Zhejiang J&C Biological Technology Co.,Limited	+1-2135480471 +1-2135480471;	sales@sarms4muscle.com	China	10473	58
InvivoChem	+1-708-310-1919 +1-13798911105	sales@invivochem.cn	United States	6391	58
TargetMol Chemicals Inc.	+1-781-999-5354;	support@targetmol.com	United States	39040	58
SUZHOU SENFEIDA CHEMICAL CO.,LTD	+86-0512-83500002 +8618662433356	3899766280@qq.com	China	26362	58

862507-23-1()Verwandte Suche:

---

• 5-(2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate
• 5-(2-(tert-butyl)-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate
• LY2228820;LY 2228820;LY-2228820
• 5-(2-tert-Butyl-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-am
• LY2228820
• 5-[2-(1,1-DiMethylethyl)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate
• LY2228820(LY-2228820)
• LY2228820 2MsOH
• LY2228820 diMesylate
• 5-[2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-imidazo[4,5-b]pyridin-2-amine methanesulfonate
• LY2228820 (Ralimetinib) dimesylate
• LY2228820 (mesylate)
• Ralimetinib Mesylate
• RALIMETINIB DIMESYLATE (LY2228820 DIMESYLATE)
• Ralimetinib 2MsOH(LY2228820)
• CS-371
• LY2228820 (Ralimetinib)
• RALIMETINIB DIMESYLATE; LY2228820 DIMESYLATE; LY2228820 2MSOH; LY 2228820; LY-2228820
• Ralimetinib 2MsOH
• LY2228820 USP/EP/BP
• Ralimetinib dimysylate (LY2228820 dimysylate)
• Ralimetinib mesylate LY2228820 LY-2228820
• LY 2228820, p38 MAPK inhibitor
• Ralimetinib dimesylate, 10 mM in DMSO
• LY2228820 dimesylate (Ralimetinib dimesylate)
• Ralimetinib (LY2228820) dimesylate
• Ralimetinib (LY2228820) dimesylate ，S1494
• 3H-Imidazo[4,5-b]pyridin-2-amine, 5-[2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-, methanesulfonate (1:2)
• 862507-23-1
• C24H29FN62CH4O3S
• C25H33FN6O3S
• C26H37FN6O6S2
• Inhibitors
• Aromatics
• Heterocycles
• Intermediates & Fine Chemicals
• Pharmaceuticals
• Protein Kinase Inhibitors and Activators
• MAPK